Cancer begins when mutations in specific genes override the body’s built-in controls on cell division, allowing rogue cells ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Multiple myeloma is a common blood cancer affecting plasma ...

Verastem Oncology Provides Preliminary Fourth Quarter and 2025 Revenue and Business Updates and Outlines 2026 Strategic Priorities for Novel Portfolio Targeting RAS/MAPK Pathway-Driven Cancers Based ...

All right. Let's go ahead and get started. Welcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I am one of the SMID-cap biotech analysts here at JPMorgan. I'm ...

Raf kinases are components of the MAP kinase pathway, a signal transduc-tion pathway that normally controls cell growth and division downstream of activated cell surface growth factor receptors. RAF1, ...

Researchers use AI to visualize reaction pathways of colloidal quantum dots as subway maps, clarifying synthesis and speeding sensor design. This innovative achievement allows AI to analyze complex ...

The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. Glucagon-like peptide-1 receptor agonists (GLP1-RA) are a ...

Plasma membrane potential has been linked to cell proliferation for over 40 years in vertebrate cells. In this study, we experimentally demonstrated that membrane depolarization promotes mitosis and ...

A recent Harris Poll survey revealed that 42 percent of U.S. adults have thought about or intend to move abroad to enhance their lifestyle or financial well-being. This figure climbs to 63 percent ...

Erasca, Inc. focuses on developing novel targeted therapies for solid tumors, particularly through the RAS/MAP kinase pathway, with a promising yet early-stage pipeline. The company’s lead program, ...

In this second installment of MedPage Today's virtual roundtable series on pediatric low-grade glioma, moderator Jason Fangusaro, MD, of Emory University School of Medicine in Atlanta, is joined once ...